Team

Tomas Hode,  Ph.D. CEO

Tomas Hode,  Ph.D.
CEO

Lu Alleruzzo, MBA COO & President

Lu Alleruzzo, MBA
COO & President

Joseph Raker, Ph.D.   Chief Drug Dev. Officer

Joseph Raker, Ph.D.  
Chief Drug Dev. Officer

Theresa Visarius, Ph.D.   VP Business Dev.

Theresa Visarius, Ph.D.  
VP Business Dev.

Siu Kit Lam, Ph.D.         VP Science & Research

Siu Kit Lam, Ph.D.        
VP Science & Research

Troy Jiao, MFA,           VP Asian Business Dev.

Troy Jiao, MFA,          
VP Asian Business Dev.

Monica Croke, Ph.D. Clinical Consultant

Monica Croke, Ph.D.
Clinical Consultant

Board

Bobby Sandage, Ph.D. Chairman

Bobby Sandage, Ph.D.
Chairman

Charlie Bolten, Biogenerator

Charlie Bolten,
Biogenerator

David Smoller, Ph.D. Cultivation Capital

David Smoller, Ph.D.
Cultivation Capital

Robert Nordquist, Ph.D. Inventor

Robert Nordquist, Ph.D.
Inventor

Wei Chen, Ph.D.     Inventor

Wei Chen, Ph.D.    
Inventor

Tomas Hode, Ph.D.       CEO

Tomas Hode, Ph.D.      
CEO

Lu Alleruzzo, MBA     COO & President

Lu Alleruzzo, MBA    
COO & President

 

Advisors

Mark Naylor, M.D.     Clinical Development

Mark Naylor, M.D.    
Clinical Development

Michael Hamblin, Ph.D. Non-clinical Development

Michael Hamblin, Ph.D.
Non-clinical Development

Grant Williams, M.D. Regulatory Strategy

Grant Williams, M.D.
Regulatory Strategy

Daniel Von Hoff, M.D. Clinical Development

Daniel Von Hoff, M.D.
Clinical Development

Richard Levenson, M.D. Clinical Development

Richard Levenson, M.D.
Clinical Development

Peter Jenkins, MBA Device Development

Peter Jenkins, MBA
Device Development

Pamela Klein, M.D.   Clinical Development

Pamela Klein, M.D.  
Clinical Development

John Weatherspoon, J.D./Ph.D.                           IP Protection

John Weatherspoon,
J.D./Ph.D.                           IP Protection

Bernard Fox, Ph.D.   Non-clinical Development

Bernard Fox, Ph.D.  
Non-clinical Development

David W. Anderson, Ph.D. Non-clinical Development  

David W. Anderson, Ph.D.
Non-clinical Development